Actionnariat et activité des initiés pour MacroGenics, Inc. (MGNX): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $4.08 |
| Capitalisation | $259M |
| Bourse | NASDAQ |
| Pays | US |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $84.1M | $211.7M | $220.1M | $126.5M | $181.1M | $123.5M | $108.9M | $101.0M | $182.8M | $57.2M |
| Placements à Court Terme | $192.9M | $93.4M | $12.7M | $89.3M | $91.4M | $120.1M | $45.5M | $128.8M | $18.8M | $132.7M |
| Créances | $2.8M | $13.6M | $29.6M | $12.7M | $23.1M | $10.4M | $56.2M | $10.4M | $4.3M | $13.4M |
| Stocks | -$8.0M | 0 | 0 | 0 | 0 | $4.4M | $1.5M | $1.2M | 0 | $7.9M |
| Actifs Courants | $283.9M | $322.3M | $269.1M | $239.8M | $312.6M | $279.6M | $222.2M | $251.3M | $217.5M | $219.9M |
| Immobilisations Corporelles | $18.0M | $50.0M | $56.7M | $68.4M | $61.5M | $54.3M | $56.9M | $45.7M | $42.6M | $35.5M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $311.3M | $373.9M | $332.1M | $312.5M | $378.7M | $335.2M | $289.5M | $298.4M | $261.7M | $256.8M |
| Dettes Fournisseurs | $4.0M | $2.5M | $4.0M | $4.3M | $8.0M | $15.5M | $4.9M | $6.4M | $5.0M | $4.8M |
| Dette à Court Terme | $1.6M | $298000 | 0 | 0 | 0 | 0 | $4.7M | 0 | 0 | $5.2M |
| Passifs Courants | $27.3M | $49.8M | $59.9M | $45.2M | $50.7M | $74.6M | $48.6M | $56.1M | $55.5M | $43.1M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $70.0M |
| Passifs Totaux | $42.5M | $74.6M | $89.3M | $81.9M | $82.9M | $95.6M | $147.5M | $145.8M | $145.6M | $201.3M |
| Réserves | -$292.7M | -$312.3M | -$490.3M | -$642.1M | -$771.8M | -$973.9M | -$1.09B | -$1.10B | -$1.17B | -$1.24B |
| Capitaux Propres | $268.8M | $299.2M | $242.9M | $230.6M | $295.9M | $239.6M | $142.0M | $152.6M | $116.1M | $55.6M |
| Dette Totale | $1.9M | $298000 | 0 | $30.6M | $29.2M | $25.5M | $34.8M | $34.0M | $37.5M | $106.8M |
| Dette Nette | -$275.1M | -$304.8M | -$232.9M | -$185.2M | -$243.3M | -$218.1M | -$119.5M | -$195.8M | -$164.2M | -$83.2M |
| Fonds de Roulement | $256.6M | $272.5M | $209.2M | $194.6M | $261.9M | $205.0M | $173.6M | $195.2M | $162.0M | $176.8M |
Santé financière
| Dette / Capitaux propres | 0.82 |
| Ratio de liquidité | 2.96 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -6.01 |
Rentabilité
| Rentabilité des capitaux propres | -31.27% |
| Rentabilité du capital investi | -2.36% |
| Rentabilité des actifs | -4.22% |
| Marge brute | 50.44% |
| Marge opérationnelle | -24.30% |
| Marge nette | -8.70% |
Entreprises liées: CLNN · CNTB · CNTX · COYA · IFRX · ORMP · OVID
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de MGNX: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions